How to Compare Liposomal NAD+ Powder Specifications From Different Manufacturers

Two suppliers can send you a liposomal NAD+ powder specification sheet with the same eight headings and still leave you unable to compare them line by line. The obstacle is rarely secrecy: many terms on a sheet are not standardized, and the same label can describe a different basis, a different test method, or a different scope. This guide sets out a reconciliation method for putting several liposomal NAD+ powder specifications onto one basis, so a buyer can separate a real difference from a difference in reporting convention. It stays on specifications and evidence, with no ranking of companies and no commercial terms.

Why Two Spec Sheets Look Alike and Still Are Not Comparable

A specification sheet is a summary of one manufacturer's internal control strategy, not a page from a shared standard. Three things move between sheets even when the wording is identical: definition (what the number describes), method (how it was generated, at what detection capability), and scope (which grade, which site, which lot).

Skip the alignment and two errors follow. A false difference makes you reject material that is equivalent but reported on another basis. A false match makes two sheets agree on a headline number while describing different things.

Practical rule: align the basis first, then compare values. A number without its basis is not a specification.

The Five Basis Traps That Create False Differences and False Matches

Five items account for most of the reconciliation work on a liposomal powder. Each one is a place where a single word carries two meanings.

Basis trap	What differs between sheets	Question that resolves it
Declared content basis	Active assayed directly, or a percentage derived from input ratio or total solids.	Is the percentage the active on a stated moisture basis, and what converts input to declared content?
Encapsulation efficiency	Separation method or differential calculation; the denominator may differ.	Which definition and separation step, and is free (unencapsulated) active reported separately?
Particle size	Z-average from dynamic light scattering, a volume-weighted mean, or a peak maximum.	Provide Z-average, polydispersity index and span together, and state the distribution weighting.
Limit items and methods	The same numeric limit can sit above or below the method's limit of quantification.	For lead and total plate count: method, quantification limit, and whether the figure is a specification limit or a reporting limit.
Certification scope	A certificate covers a management system, not a grade or product line.	Certificate number, issuing body, validity dates, site addresses, and written confirmation this grade sits inside the scope.

Trap 1: Content on the Active Basis or on Total Solids

The declared figure usually sits between 10% and 70%, with carrier making up the balance, and the two ends behave differently on the bench. At the low end the carrier dominates, so flow, blending uniformity and powder handling volume matter most. At the high end — 50% grades are the common working point, behind a 99% purity raw material — carrier is scarce, so hydration, solids loading and dispersion carry more risk. Neither end is better; both must be compared on the same basis.

Trap 2: Encapsulation Efficiency — Definition Before Value

Efficiency in the 85%–95% band looks like one concept. It is not. A separation method physically isolates free from encapsulated active and analyses each pool; an indirect method takes the total assay and subtracts free active from the external phase. The two give adjacent-looking numbers that are not interchangeable, because the denominator — active added, active recovered, total assay — can differ. Ask which definition and separation step apply, and whether free active is reported. Without a free-active value, the efficiency figure cannot be reconciled with anything.

Trap 3: Particle Size — A Mean Is Not a Distribution

A single average diameter is the most over-read number on a liposomal sheet. Ask for Z-average, polydispersity index and distribution span together, plus the weighting, following the dynamic light scattering convention used to verify liposomal NAD+ powder quality. Intensity-weighted means are dominated by a few large scatterers, so a modest Z-average can sit above a wide upper tail, and a polydispersity index alone does not describe that tail. Confirm dilution medium, temperature and reporting convention as well.

Trap 4: Limit Items — Numbers Without Detection Capability

Lead and microbiological limits are where comparison most easily breaks, because the limit and the method are separate commitments. A lead figure of <0.1 ppm means little if the laboratory quantifies only down to a higher value, and a result below a higher quantification limit says nothing about the specification. Ask for the elemental method, the quantification limit and the raw result. For total plate count, where our reference is <1,000 cfu/g, ask for method reference, media and incubation, since counts from unlike media are not the same measurement. The same discipline of declaring method performance underlies evaluating the purity and quality of liposomal NAD+ powder.

Trap 5: Certification Scope — A System, Not a Batch

Normalizing the Comparison: One Table, One Basis

The working tool is one table that forces every value onto a stated basis before it is compared: parameter, basis question, acceptable evidence, and a note on what frequently goes missing. Fill the rows from every sheet you hold, then compare within a row rather than down a column.

Parameter	Basis question	Acceptable evidence	Note
Declared active content	Assay value, or derived from input ratio?	Assay with reference standard on a stated moisture basis, plus the calculation	Ask for the conversion from input
Encapsulation efficiency	Separation-based or differential?	Method description, formula and denominator	Compare only like definitions
Free (unencapsulated) active	Reported at all, and from the same run?	A separate free-fraction value in the same report	Often missing, which blocks reconciliation
Particle size	Z-average, mean, or peak maximum?	Report showing Z-average, polydispersity index and span	State the instrument and convention
Distribution weighting	Intensity, volume or number?	Report header showing the weighting used	Intensity weighting is skewed by large particles
Lead	Which method and quantification limit?	Method name, quantification limit, raw result	A limit below quantification is uninformative
Total plate count	Which method, media and incubation?	Method reference with the result	Unlike media are not comparable
Moisture and appearance	Instrumental moisture, or visual only?	Moisture result plus a colour reference	Both drive flow and blending
Stability and shelf life	Accelerated only, or real-time supported?	Accelerated protocol with time points, plus long-term data	Ask which grade the data covers
Certification scope	Which site, and which product lines?	Certificate numbers with scope statements	System certification is not a batch result

A Question Set to Copy Into Your Inquiry

The fastest way to normalize several sheets is to send the same list to each contact. These are specification and evidence questions only.

• Is the declared active percentage an assay value on a stated moisture basis, and how does it convert from input?
• Which encapsulation efficiency definition applies, separation-based or differential, and what is the denominator?
• Is the free (unencapsulated) fraction reported separately, from the same analytical run?
• Can you provide Z-average, polydispersity index and distribution span together, with the weighting stated?
• Which reporting convention and dilution medium are used for particle size?
• For lead: which method, which quantification limit, and what is the raw result for this batch?
• For total plate count: which method reference, media and incubation conditions?
• Which stability protocol was used, which grade does it cover, and which time points exist?
• For each certificate: number, issuing body, validity period and site scope?
• Can you provide results for three or more consecutive batches of the same grade, and describe your change notification process?

Comparing Batch Consistency, Not Just One Certificate

Three items belong in the same conversation: retention samples held by both sides, so lots can be re-tested later; a re-test arrangement stating what is tested, by whose method, and how disagreement is resolved; and a documented change notification practice covering raw material source, process parameter and site changes, with an agreed split between notification and full re-qualification. Time points and stress conditions follow the ICH stability guideline in the references, and our technical guide to liposomal NAD+ powder stability applies the same logic to procedure transfer.

Our Reference Specification, Stated on One Basis

To make the reconciliation concrete, here is the EmerWell liposomal NAD+ powder reference specification with the basis written next to each value. Require the same clarity from any sheet you compare it with; the factors that affect liposomal NAD+ powder shelf life explain how the storage claim is supported.

Parameter	Stated basis	Reference value	Method
NAD+ content	Active assay on a stated moisture basis	10%–70%, with 50% as the commonly used grade; 99% purity raw material	HPLC
Encapsulation efficiency	Separation-based, with the free fraction reported	85%–95%	HPLC with a separation step
Particle size	Z-average with polydispersity index and span, weighting stated	Reported per batch	DLS
Structure confirmation	Bilayer morphology	Reported per batch	TEM
Lead (Pb)	Specification limit above the stated quantification limit	<0.1 ppm	Elemental method named on the batch COA
Total plate count	Plate count on the media stated in the report	<1,000 cfu/g	Microbiological method named on the batch COA
Appearance	Visual assessment against a colour reference	Pale yellow to white	Visual
Shelf life	Supporting stability data on this grade	Up to 24 months	Stability protocol

Technical Questions That Reveal Process Depth

Once the sheets are on one basis, the remaining question is whether the process behind them is understood. Technical questions answer that faster than any document set, and they stay entirely on the technical side.

• How is free active separated from the encapsulated fraction, and how is that step validated?
• Which process parameters most influence encapsulation efficiency on your line, and how are they controlled?
• How are particle size and distribution targets set, and what batch-to-batch variation is measured?
• What limits shear and temperature during processing, and how are those limits verified?
• How is moisture controlled during drying and packaging, and what range is released against?
• How is bilayer structure confirmed rather than a lipid-active association, and on what fraction of lots?

Incoming Verification: Sampling, Re-test Triggers and Deviations

Specification work ends with a written verification plan, because reconciliation happens at the bench as well as the desk. Agree which attributes are accepted on the certificate and which are confirmed on receipt, then define the sampling plan, the number of increments, and retained samples held by both parties.

Write down re-test triggers instead of leaving them to judgement: any visible deviation from the agreed appearance, moisture outside the agreed range, a content result differing from the certificate by more than the agreed tolerance, encapsulation efficiency outside the band, particle size or polydispersity index outside the band, and any microbiological result at or over a limit. When a trigger fires, follow a fixed path: hold the lot, notify both quality contacts in writing, repeat the test in parallel, and if the results still disagree, resolve the dispute with a pre-agreed referee method at a third laboratory. Route confirmed differences into the change notification process. A routine look at how liposomal NAD+ powder is made helps a receiving team interpret what a deviation points to.

Request Specifications, COAs and Samples

To run this reconciliation on liposomal NAD+ powder, we will send the reference specification, a batch certificate of analysis and a sample so your team can test the material in your own matrix. We can also walk through the basis definitions behind each line, the method documentation for assay, particle size and structure confirmation, the stability data supporting up to 24 months, and the certification scope statements. Start from the liposomal NAD+ powder product page, write to info@emerwell-bio.com, or review the wider liposomal raw material range, background on the factors that matter when choosing NAD+ powder manufacturers, and what liposomal products actually look like.

References

1. International Council for Harmonisation. Stability Testing of New Drug Substances and Products Q1A(R2). ICH, 2003. https://database.ich.org/sites/default/files/Q1A%28R2%29%20Guideline.pdf
2. International Council for Harmonisation. Validation of Analytical Procedures Q2(R2). ICH, 2023. https://database.ich.org/sites/default/files/ICH_Q2%28R2%29_Guideline_2023_1130.pdf
3. International Organization for Standardization. ISO 22412:2017 Particle size analysis — Dynamic light scattering (DLS). ISO. https://www.iso.org/standard/65410.html
4. International Organization for Standardization. ISO 22000:2018 Food safety management systems — Requirements for any organization in the food chain. ISO. https://www.iso.org/standard/65464.html
5. U.S. Food and Drug Administration. 21 CFR Part 111 — Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements. eCFR. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-111

Disclaimer: This article is written for dietary supplement ingredient sourcing, quality and product-development professionals. It describes raw material specifications, analytical reporting conventions and verification practice only. It is not medical or nutritional advice, it makes no statement about any finished product's effects on health, and it does not replace the regulatory assessment required in any individual market. Specification values quoted are our own reference values for the EmerWell liposomal NAD+ powder line and are confirmed per batch on the certificate of analysis.